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The Problem: National Incidence Trends
Common Cancers

3rd

Colorectal cancers are the third most
common cancers in both men and
women in the US
Prevalence

1 in 22

One in 22 men and one in 24
women will receive a colorectal
cancer diagnosis in their lifetime
National Trends

2004-present
American Cancer Society Colorectal Cancer Facts & Figures 2017-2019

Trends show a recent accelerated
decline in colorectal cancer
incidence, attributed to increased
screening and subsequent
intervention

The Problem: Local Screening Trends
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Primary Care
HHHN is one of the largest providers
of primary care in Upstate New York

2017

2018

Federally Qualified Health Center

Safety Net

This network provides care to a large
geographic area that is otherwise
largely medically underserved

The Data

Under Goal
The screening rates show little trend
from health center to health center
and little improvement

Comparison at
the State and
National Level
• As a network, our best
screening rates in recent years
are below 63%

• While the state of New York is in
the second-highest bracket for
screening rates, HHHN still sits
in the lowest
• This is complicated by our role
as an FQHC, with a large
catchment area and
socioeconomically diverse
patient population

American Cancer Society Colorectal Cancer Facts & Figures 2017-2019

The Need
• We serve a largely rural
population
• Few available GI centers capable
of colonoscopy

• Large need for screening options
with greater availability,
accessibility, and geographic
flexibility

“Gastroenterology Adirondacks” searched in Google Maps

The Public Health Cost
National Expenditure for CRC

$16.3 Billion

By cancer type, national expenditure
on colorectal cancer is second only
to female breast cancer

Typical Stage IIb Case Study

$124,425

American Cancer Society case study
reports care for a typical Stage IIb
CRC patient costing $124,425 in the
first year of treatment alone
Local Coverage

51.5% Commercial
“The Costs of Cancer,” American Cancer Society Cancer Action Network, 2017.

HHHN patient population eligible for
CRC screening (with insurance on
file for search): 51.5% commercial,
38.7% Medicare, 9.7% Medicaid

The Community Perspective: An Interview
with HHHN Care Manager, Debra Shay
Financial Barriers to
Access:
Large copays for screening
services, particularly
colonoscopy
Expense of return postage for
at-home screening options
Need to pay no-show fees at
local GI offices before
scheduling new procedures

Social Support
Barriers to Access:
Availability of family/friends to
escort patients to and from
colonoscopy (required if using
sedation)
Availability of family/friends to
observe and remain available to
patients after colonoscopy in
case of complications

Personal Barriers to
Access:
Fear of significant screening
procedures
Potential embarrassment of
returning at-home samples inperson

The Community Perspective: An Interview with the Cancer Services Program

“It’s the people who are
disenfranchised, people who
don’t get to go to their well
care checks, who need to be
engaged.”

Kathryn
Cramer

Gail
Infante

“I’m so happy the medical
community is looking beyond
colonoscopy, because we meet
with so many people who are
not up to date on screening
and have no intention of
getting a colonoscopy.”

“Some people don’t want to be
found, it’s not exactly safe right
now, but we’re trying to find
trusting relationships with
gatekeepers in the community, so
hopefully we can reach that [New
American/Immigrant] group.”

Kathryn
Cramer

Resources

Methods: Data and Design
• Data Acquisition: with massive support from Erin Dunn and Kelly Piotrowski
from HHHN’s Population Health department, we pulled three years’ data from
Athena Health records to identify trends in successful and failed CRC screening
measures
• Data Analysis: looked at age, insurance type, income, geography, individual
health centers, individual providers, and risk factors and comorbidities (e.g.
obesity, homelessness, asthma, COPD, diabetes, hypertension, osteoporosis) to
determine most at-risk populations
• Literature Review: underwent a literature search to find evidence-based
interventions in similar populations
• Project Approval: devised and approved a pilot FITKit mailing program
including cost estimates/approval, written outreach reviewed by HHHN’s
marketing department, and presentation of the pilot plan itself to the network

Methods: Intervention
We mailed FITkits to a cohort of HHHN primary care patients who:
Are currently failing the CRC
screening measure

Haven’t seen a provider in
2018

Are age 50-75

Have a BMI greater than or
equal to 30 (obese)

Have 0-5 comorbidities

This mailing was preceded by an introduction email for the initiative (1 week prior)

Kits included a second introductory letter for the initiative, health center call-back numbers, the existing fact sheet
included with FITkits in-office, and pre-stamped, pre-addressed return envelopes for samples

Two automated phone reminders were released, at ~ 1.5 and 3 weeks after the kit mailing, encouraging patients to
complete the screening

Why this Cohort?

Includes important risk factor for CRC:
Obesity

Chosen Cohort = 389 Patients

Well distributed among 17 health
centers → more generalizable

Opportunity to reach patients not
coming into our offices (where we
already hand out kits)

Strong
Pilot
Group

Obese men: RR ~ 1.5 for colon cancer
and RR ~ 1.2 for rectal cancer

Obese women: RR ~ 1.2 for colon
cancer and R ~ 1.1 for rectal cancer

Support from the Literature
Effect of Colonoscopy Outreach vs
Fecal Immunochemical Test
Outreach on Colorectal Cancer
Screening Completion

Effectiveness and Cost of Multilayered
Colorectal Cancer Screening
Promotion Interventions…
Kemper et al, 2018
-

This study showed a 31% return
rate in their mailed FIT kits at
involved FQHC’s in Washington
State

-

Study used additional
mailed/telephone reminders

-

Evaluation of Interventions Intended
to Increase Colorectal Cancer
Screening Rates in the United States
Dougherty et al, 2018

Signal et al, 2017
-

This RCT compared colonoscopy
mailed outreach and FIT kit
mailed outreach with usual care
among individuals 50-64 years
old, receiving primary care at a
safety-net institution.

-

Found colonoscopy outreach to
have higher rates of process
completion (38.4%) than FITkit
outreach/mailing (28.0%), but
maintained a stringent definition
of process completion

-

Required FITkit patients to follow
up on abnormal test results with
colonoscopy to be considered
‘complete’

Found cost per completed
screening to be just under $40

-

This meta-analysis looked at
many RCT’s investigating
different interventions intended
to increase CRC screening rates
and found that FBT outreach
had the best advantage over
usual care

-

RR (of completing screening) of
2.26 and CI of 1.81-2.81 (better
than patient navigation, patient
education, and patient
reminders)

The Results
In mid-January, 2019, FITKits were mailed out to nearly 400 HHHN patients
who were out of date with screening recommendations and subsequently at
risk of having undetected colorectal cancer

We plan to track FITKit returns within this cohort over the coming months,
sending out additional reminders accordingly

The data we collect will direct future efforts for this pilot quality improvement
project

Evaluating Effectiveness

Strengths

Limitations

Reached a population that was not
receiving regular preventative care

High financial cost, price per completed
screening still to be determined

Equally effective for even the most rural
patients in population

Time-consuming mailing assembly process

Provided a quick, simple cancer
screening option without need to
schedule appointment or procedure
Eliminated travel time and cost, hopefully
improving accessibility
Worked with population generalizable to
much of HHHN

Size of cohort limited by financial and time
burden
Potential issues with follow-up for inaccessible
patients with positive test results
Visual/language demands of included kit
instructions
Workflow of retroactively ordering screening

Future Directions

DATA ANALYSIS

COMPARISON

REPETITION

Evaluate
effectiveness by
collecting data on
FITKit returns,
consider analysis of
cost per returned
screening

Consider comparing
returns on mailed
kits to those handed
out in-office

Explore annual
mailings for any
patients receptive to
this mailed
screening option

ASSESSMENT
Assess any barriers
to follow-up and
continued workup
for any positive
screening results

EXPANSION
Based on collected
data, consider
expanding pilot to
broader HHHN
population

Recommendations
Streamline
Consider streamlining
mailing process:
• Estimated person-hours for
mailing assembly for current
cohort ~21
• Eliminate need to disassemble
and reassemble every FITKit by
printing patient ID stickers and
including postage and return
label as loose components
with backing paper intact

Consider

Learn

Consider measures to
increase accessibility and
inclusivity:

Learn from our
neighbors at the Cancer
Services Program:

• Consider picture-based
instructions, eliminating need
to read small font or have
English language proficiency

• Consider small rewards (e.g. $5
Stewart’s giftcard) included
with completed FITKit results
• Consider radio ads for
outreach
• Establish method for
individuals who are out-ofdate with screening to request
FITKit mailing, without need for
in-person communication

Where do we stand today?
26 Kits Returned

7.14% Completion

Just under a month after mailing
FITKits to a pilot group of Hudson
Headwaters patients, we have seen 26
mailed kits returned to our offices for
processing

With most recent literature suggesting
~30% screening completion on similar
FITKit mailing initiatives, 7.14% returns is a
promising start near the one-month mark

$427 in FITKits
New FITKit purchasing for the entire
cohort cost the network nearly $427,
with additional costs of the initiative
attributable to mailing envelopes,
postage, and printing

16% of Kit Cost
FITKit purchasing for this QI project
represented only 16% of the networks total
FITKit purchasing expenses in 2018 (with
record lowest FITKit spending this year)
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